Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Disease

Staphylococcal Sepsis

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 11, 2026 · PHASE 2 TRIAL

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

ClinicalTrials.gov

Phase 2 RCT registered but not yet reporting results; addresses a mechanistic hypothesis from case series and animal data with no prior RCT evidence.

PreliminaryTodd C. Lee MD MPH FID Staphylococcus Aureus Bacteremia Ertapenem

Reported

Planned enrollment60

PhasePhase 2

Primary outcome measureClinical success, Day 5

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support